A minimally invasive surgical platform against pancreatic and biliary tract cancers
IgnitePLASMA
(2024 - 2028)
Pancreatic cancer is one of the deadliest cancers, as it is detected in late stages and with very few effective treatments available to patients. The IgnitePLASMA project will develop a new solution using cutting-edge technology in plasma physics, computational (in silico) modeling, and pancreatic and biliary cancer biology. It will combine multiscale simulations and intelligent systems in plasma control, while taking input from preoperative diagnostics to train the models to determine the appropriate conditions for treatment. The developed technology will be demonstrated through in vivo biological experiments, and this project will lay the foundation for clinical trials in the treatment of pancreatic and biliary tract cancer. The University of Cyprus announces the launch of the European project for research in the field of computational engineering, plasma physics, and cancer treatment research, entitled IgnitePLASMA. The research project will be funded for four years by the European Innovation Council and UK Research and Innovation. The project is a joint venture between the Sorbonne University, the University of Patras, Synnous Ltd from the UK, the Bank of Cyprus Oncology Center, and the University of Cyprus. The consortium speaker is Vasileios Vavourakis, Cyprus.